Screening for anti-ganglioside antibodies in hypocretin-deficient human narcolepsy
Autor(es): Overeem Sebastiaan,Geleijns Karin,Garssen Marcel P J,Jacobs Bart C,van Doorn Pieter A,Lammers Gert Jan
Resumo: Narcolepsy is a sleep disorder caused by defective hypocretin (orexin) neurotransmission. It is thought to result from an autoimmune destruction of hypocretin producing neurons. Recently, low hypocretin levels were found in patients with Guillain-Barré syndrome, a post-infectious immune-mediated disorder in which a variety of circulating antibodies against neuronal gangliosides are found. We therefore considered gangliosides to be candidate antigens in narcolepsy as well, and screened for the presence of a panel of serum anti-ganglioside antibodies in a group of 28 well-characterized narcoleptic patients. We did not find a correlation between increased titers of anti-ganglioside antibodies and hypocretin-deficient narcolepsy. This study does not support the hypothesis that an autoimmune response is involved in narcolepsy. However, as an autoimmune attack may be selective and/or transient, future studies are needed to ultimately refute or confirm the autoimmune hypothesis.
Palavras-Chave: Narcolepsy; Hypocretin; Orexin; Autoimmune; Guillain-Barré syndrome; GangliosideAntibody
Imprenta: Neuroscience Letters, v. 341, n. 1, p. 13-16, 2003
Identificador do objeto digital: 10.1016/S0304-3940(03)00085-5
Descritores: Guillain-Barre Syndrome - Immune response ; Guillain-Barre Syndrome - Proteins ; Guillain-Barre Syndrome - Antibodies
Data de publicação: 2003